Cargando…
STAT3-NAV2 axis as a new therapeutic target for rheumatoid arthritis via activating SSH1L/Cofilin-1 signaling pathway
Autores principales: | Wang, Ran, Cai, Jianghong, Chen, Keyuan, Zhu, Menglin, Li, Zhaoyi, Liu, Hua, Liu, Tiantian, Mao, Jianchun, Ding, Qian, Zhu, Yi Zhun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262938/ https://www.ncbi.nlm.nih.gov/pubmed/35798713 http://dx.doi.org/10.1038/s41392-022-01050-7 |
Ejemplares similares
-
Vascular NRP2 triggers PNET angiogenesis by activating the SSH1-cofilin axis
por: Luo, Xi, et al.
Publicado: (2020) -
NAV2 positively modulates inflammatory response of fibroblast‐like synoviocytes through activating Wnt/β‐catenin signaling pathway in rheumatoid arthritis
por: Wang, Ran, et al.
Publicado: (2021) -
The Cofilin Phosphatase Slingshot Homolog 1 (SSH1) Links NOD1 Signaling to Actin Remodeling
por: Bielig, Harald, et al.
Publicado: (2014) -
Signaling pathways in rheumatoid arthritis: implications for targeted therapy
por: Ding, Qian, et al.
Publicado: (2023) -
SSH1 impedes SQSTM1/p62 flux and MAPT/Tau clearance independent of CFL (cofilin) activation
por: Fang, Cenxiao, et al.
Publicado: (2020)